1-3 of 3
Evert-Jan Wils
Close
Sort by
Journal Articles

Stem Cell Factor (SCF) Improves Thymopoiesis After Experimental Hematopoietic Stem Cell Transplantation In Both a Murine BMT Model and In “human Immune system” (HIS) Mice, Receiving a Human Stem Cell Graft.

Elwin J Rombouts, PhD, Evert-Jan Wils, Irene Van Mourik, Nicolas Legrand, PhD, Hergen Spits, Prof., Dr., Jan J. Cornelissen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3725.
https://doi.org/10.1182/blood.V116.21.3725.3725
Published: 2010
Journal Articles

Failure to Recover Thymopoiesis After Allogeneic Hematopoietic Stem Cell Transplantation Predicts for High Incidence of Opportunistic Infections and Non-Relapse Mortality

Evert-Jan Wils, MD, Bronno van der Holt, PhD, Annoek E.C. Broers, MD, PhD, Sandra J. Posthumus-van Sluijs, Jan W. Gratama, MD, PhD, Eric Braakman, PhD, Jan J. Cornelissen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 832.
https://doi.org/10.1182/blood.V116.21.832.832
Published: 2010
Journal Articles

Acceleration and Enhancement of T-Cell Recovery and Immune Competence by Flt3-Ligand (Flt3L) Following BMT with Low Numbers of Progenitor Cells in Immune Deficient Mice.

Evert-Jan Wils, MD, Annoek E.C. Broers, MD, Georges M.G.M. Verjans, PhD, Bert Niesters, PhD, Albert D.M.E. Osterhaus, PhD, Hergen Spits, PhD, Bob Lowenberg, MD, PhD, Gerard Wagemaker, MD, PhD, Erik Braakman, PhD, Jan J. Cornelissen, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 47.
https://doi.org/10.1182/blood.V104.11.47.47
Published: 2004